Ocuphire Pharma Inc. buy Alliance Global Partners
Start price
20.03.24
/
50%
€1.84
Target price
20.03.25
€18.44
Performance (%)
-23.53%
Price
26.04.24
€1.51
Summary
This prediction is currently active. The prediction for Ocuphire Pharma Inc. disappoints with a performance of -23.53%. This prediction currently runs until 20.03.25. The prediction end date can be changed by Alliance_Global_Part at any time. Alliance_Global_Part has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ocuphire Pharma Inc. | -7.927% | -7.927% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Alliance_Global_Part for this prediction
In the thread Ocuphire Pharma Inc. diskutieren
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its price target lowered by analysts at Alliance Global Partners from $24.00 to $20.00. They now have a "buy" rating on the stock.
Ratings data for OCUP provided by MarketBeat